|
Jan 10
|
Swiss Pharma Giants Who Missed Boat on Obesity Fight to Stay Relevant
|
|
Jan 9
|
Cytokinetics (CYTK) Rises on Reports of Buyout by Novartis
|
|
Jan 9
|
Stocks to Watch Tuesday: Boeing, Match, HPE, JetBlue
|
|
Jan 2
|
Voyager Therapeutics shares jump after $1.2 billion deal with Novartis
|
|
Dec 27
|
Novartis (NVS) Outperforms Broader Market: What You Need to Know
|
|
Dec 26
|
The Zacks Analyst Blog Highlights Procter & Gamble, PepsiCo, Novartis, Occidental Petroleum and DuPont de Nemours
|
|
Dec 20
|
Novartis (NVS) Stock Moves -1.17%: What You Should Know
|
|
Dec 20
|
Roche's (RHHBY) sBLA for Xolair Gets FDA Priority Review Tag
|
|
Dec 19
|
Ionis (IONS) Out Licenses Europe Rights for HAE Drug to Otsuka
|
|
Dec 15
|
Amgen finds a new top scientist in Novartis veteran Bradner
|
|
Dec 14
|
Novartis (NVS) Stock Sinks As Market Gains: Here's Why
|
|
Dec 11
|
Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and statistically significant proteinuria reduction in patients with C3 glomerulopathy (C3G)
|
|
Dec 11
|
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Dec 10
|
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
|
|
Dec 8
|
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
|
|
Dec 8
|
Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod
|
|
Dec 7
|
Radiopharma startup Artbio raises $90M in sign of field’s momentum
|
|
Dec 6
|
Novartis (NVS) Gets FDA Nod for Rare Blood Disorder Drug
|
|
Dec 6
|
Novartis gets FDA approval of closely watched rare disease drug
|
|
Dec 6
|
Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
|